| Product ID |
Product Name |
CAS# |
Purity |
| D483622 |
tert-Butyl 3-formylmorpholine-4-carboxylate |
833474-06-9 |
98% |
| Y3166999 |
Pyrimidine,2,4-dichloro-6-(4-fluorophenyl)- |
833472-84-7 |
97% |
| D751556 |
4-Chloro-2-ethoxycarbonylphenylboronic acid |
850568-61-5 |
95% |
| Y1046489 |
(4-Ethoxy-3,5-dimethylphenyl)boronic acid |
850568-59-1 |
98% |
| Y1260811 |
(3-Nitro-4-isobutylphenyl)boronic acid |
850568-57-9 |
97% |
| Y1260941 |
Boronic acid,B-[4-(1-methylpropyl)phenyl]- |
850568-56-8 |
95% |
| D751557 |
4-(2-(DIMETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID, HCL |
850568-22-8 |
98% |
| Y1260994 |
(4-(Hydrazinecarbonyl)phenyl)boronic acid |
850567-95-2 |
95% |
| Y3206193 |
1-Pentanol, 4-amino-4-methyl- |
85054-53-1 |
95% |
| Y3210065 |
Uridine5'-(tetrahydrogen triphosphate), 2',3'-dideoxy- |
84445-38-5 |
95% |
| Y1265246 |
2-(3,5-dimethylphenoxy)acetohydrazide |
83798-15-6 |
95% |
| Y1046491 |
(trans,trans)-4'-Propyl-[1,1'-bi(cyclohexan)]-4-ol |
82832-72-2 |
97% |
| Y1265181 |
(R)-1-(1-(4-FLUOROPHENYL)ETHYL)PIPERAZINE |
862270-48-2 |
95% |
| D956953 |
1-(p-Tolyl)cyclohexanecarboxylic acid |
84682-27-9 |
98.0% |
| Y3295354 |
N,2-Dimethyl-N-phenylbutanamide |
84434-18-4 |
98 - 100% (GC) |
| Y3205436 |
Benzyl (4-(hydroxymethyl)bicyclo[2.2.2]octan-1-yl)carbamate |
864063-55-8 |
95% |
| Y3318649 |
2,3,6-Trichloro-4-(trifluoromethyl)aniline |
86399-04-4 |
97% |
| Y3199089 |
[3-chloro-2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl]acetic acid |
851208-01-0 |
95% |
| Y1344719 |
Boronic acid,B-2-pyrimidinyl- |
851199-85-4 |
98% |
| Y3155007 |
Ethyl 3-(dimethylamino)butyrate |
85118-28-1 |
97% |
| Y3199090 |
Benzenamine,2-(1-methyl-1H-tetrazol-5-yl)- |
858484-20-5 |
95% |
| D956930 |
3-Ethoxy-2-fluorophenylboronic acid |
855230-61-4 |
98+% |
| Y3154225 |
5-Allyl-4,6-dichloro-2-methylpyrimidine |
85826-33-1 |
95% (stabilized with TBC) |
| Y3158096 |
5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL |
85826-32-0 |
97% |
| Y1265219 |
2-[(4-METHYLBENZYL)OXY]BENZALDEHYDE |
85825-85-0 |
95% |
| Y1265220 |
Thiophene, tetrahydro-3-isothiocyanato-, 1,1-dioxide |
85109-44-0 |
95% |
| D956931 |
(R)-3-(1-(Dimethylamino)ethyl)phenol |
851086-95-8 |
95+% |
| Y3196048 |
Benzoicacid, 4-(3-methyl-1,2,4-oxadiazol-5-yl)- |
851048-56-1 |
95% |
| Y1265167 |
4-Morpholineacetamide, a-(4-methoxyphenyl)- |
83898-16-2 |
95% |
| Y3154206 |
4-BROMO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZONITRILE |
863868-20-6 |
95% |
| Y1046479 |
1-(4-Bromo-2-fluorophenyl)cyclopropanecarboxylic acid |
872422-15-6 |
97% |
| Y3205355 |
4-amino-5-(2-methylphenyl)-2H-1,2,4-triazole-3-thione |
87239-95-0 |
96% |
| D956933 |
Ethyl 4-amino-2-nitrobenzoate |
84228-46-6 |
95+% |
| Y3198943 |
1,2-Benzenedimethanamine,N1,N1-diethyl- |
84227-68-9 |
92% |
| Y3157922 |
Benzoyl chloride, 3-bromo-2,6-dimethoxy- |
84225-91-2 |
95% |
| Y3158169 |
2-(4-Amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethyl-1H-imidazo[4,5-c]pyridin-7-ol |
842149-46-6 |
95% |
| Y3215316 |
4-(3,5-Dimethylisoxazol-4-yl)phenol |
875628-75-4 |
95% |
| Y3200623 |
Benzenemethanamine, 3-(1,3-dioxolan-2-yl)- |
875582-75-5 |
95% |
| Y3198945 |
Bicyclo[2.2.1]heptane,2-(iodomethyl)- |
858018-16-3 |
95% |
| Y3289213 |
2-Chloro-6-nitrothiazolo[4,5-b]pyridine |
857970-02-6 |
95+% |
| Y1265266 |
Benzonitrile,4-(1,2,3-thiadiazol-4-yl)- |
82894-99-3 |
97% |
| Y1336385 |
5-Methoxy-2,3-dimethyl-1H-indole |
828-94-4 |
98% |
| Y1336384 |
Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, ethyl ester, (2S)- |
828934-40-3 |
95%+ |
| Y1334670 |
Silane, (1,1-dimethylethyl)[(5-iodopentyl)oxy]dimethyl- |
85514-45-0 |
97% |
| Y1265233 |
3-ALLYL-4-ETHOXY-5-METHOXYBENZALDEHYDE |
872183-27-2 |
95% |
| Y3211523 |
1,3,4-Thiadiazol-2(3H)-one, 5-amino-3-methyl- |
85073-03-6 |
95% |
| Y1344707 |
Benzene, (12-bromododecyl)- |
85070-63-9 |
95% |
| D758646 |
9-Chloronon-1-ene |
872-06-0 |
97% |
| Y1265191 |
3-(3-METHOXYPROPYL)PIPERIDINE |
868067-67-8 |
95% |
| Y1336434 |
1H-Imidazole, 4-ethenyl-1-(triphenylmethyl)- |
86803-29-4 |
95% |
| D748862 |
5-Iodo-6-methylpyrimidin-4-amine |
83410-18-8 |
95% |
| Y3159908 |
Ethyl 2-amino-4-chlorothieno[2,3-d]pyrimidine-6-carboxylate |
847560-46-7 |
98% |
| Y3216333 |
Ethanone, 1-[2-(methylthio)-5-pyrimidinyl]- |
84755-29-3 |
95% |
| Y3199112 |
Silane, (1E)-1-buten-3-yne-1,4-diylbis[trimethyl- |
84751-16-6 |
95% |
| Y3199113 |
3-(4-FLUORO-3-METHYLPHENYL)-1-PROPENE |
842124-27-0 |
95% |
| Y1265313 |
Ethyl acetoacetate-1,2,3,4-13C4 |
84508-55-4 |
99%13C |
| Y3318213 |
2-Amino-5-nitroisonicotinic acid |
84487-09-2 |
95% |
| K02258 |
2-Isopropylpiperazine |
84468-53-1 |
95% |
| Y3205295 |
5-Isoquinolinesulfonamide, N,N-dimethyl- |
84468-22-4 |
95% |
| Y3217025 |
2-Amino-3-chloro-anthraquinone |
84-46-8 |
95% |
| Y3216661 |
Oxirane, (fluoromethyl)-, (R)- |
83398-56-5 |
95% |
| Y1336388 |
3,6,9,12,15,18,21-Heptaoxatricosanedioic acid |
83824-29-7 |
97% |
| D760315 |
Ethene,1-(2-bromo-1,1,2,2-tetrafluoroethoxy)-1,2,2-trifluoro- |
85737-06-0 |
98% |
| D758087 |
Phthalylsulfathiazole |
85-73-4 |
97% |
| Y3212065 |
1H-Indole-2,3-dione, 4,5,7-trichloro- |
828911-72-4 |
95% |
| D956939 |
POTASSIUM (3-CHLORO-4-FLUOROPHENYL)TRIFLUOROBORATE |
850623-59-5 |
95+% |
| Y1046485 |
POTASSIUM (3-BENZYLOXYPHENYL)TRIFLUOROBORATE |
850623-58-4 |
97% |
| D759453 |
(4-(N-Butylsulfamoyl)phenyl)boronic acid |
850589-32-1 |
95% |
| Y3206500 |
(6-(Benzyloxy)-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid |
850568-66-0 |
98% |
| Y1046487 |
Ethanol,2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]- |
86770-67-4 |
97% |
| Y3208110 |
3-Pyrrolidinamine, 1-(2-methyl-1-oxopropyl)- |
833483-47-9 |
95% |
| Y3206477 |
ETHYL 2-AMINO-1-METHYLCYCLOPENTANECARBOXYLATE |
85725-97-9 |
95% |
| Y3209474 |
3-(Chloromethyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole |
844499-00-9 |
95% |
| Y1046488 |
4-(2-(Piperidin-1-yl)ethoxy)benzoic acid hydrochloride |
84449-80-9 |
95% |
| Y3218267 |
Benzo[b]thiophene-3-carboxylicacid, 4,5,6,7-tetrahydro-2-isothiocyanato-, ethyl ester |
85716-87-6 |
95% |
| Y1077376 |
1H-Imidazole-1-ethanol,5-amino-2-methyl- |
84145-87-9 |
95% |
| Y1260812 |
(4-Cyano-2-nitrophenyl)boronic acid |
850568-46-6 |
98% |
| D956945 |
[4-(2-METHOXYCARBONYLETHYL)PHENYL]BORONIC ACID |
850568-44-4 |
98% |
| Y1260993 |
N-(THIAZOLINE-2-YL) 4-BORONOBENZAMIDE |
850568-30-8 |
97% |
| Y1290811 |
(3-((1H-tetrazol-5-yl)carbamoyl)phenyl)boronic acid hydrochloride |
850567-38-3 |
98% |
| D751704 |
(3-((2-Methoxyethyl)carbamoyl)phenyl)boronic acid |
850567-33-8 |
95% |
| Y3205763 |
3-Furancarboxylic acid, 5-bromo-2-methyl- |
850553-54-7 |
95% |
| Y1313333 |
1-(3-BROMO-4-METHYLPHENYLSULFONYL)MORPHOLINE |
850429-74-2 |
97% |
| Y3205440 |
2,3:4,5-Di-O-isopropylidene-L-arabitol |
84709-35-3 |
95% |
| Y3207604 |
Butanoic acid, 3-hydroxy-4-[[(4-methylphenyl)sulfonyl]oxy]-, ethyl ester |
828276-85-3 |
95% |
| Y3157877 |
2-Amino-4,6-bis(difluoromethoxy)pyrimidine |
86209-44-1 |
98% |
| Y3196177 |
2-Pyrrolidinone, 5-cyclopropyl- |
837414-95-6 |
95% |
| Y3200170 |
Pyridine, 3-(2-methyl-1H-imidazol-1-yl)- |
837376-62-2 |
95% |
| Y1260995 |
(3-Methyl-5-(trifluoromethyl)phenyl)boronic acid |
850411-13-1 |
95% |
| Y1046492 |
[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ACETIC ACID ETHYL ESTER |
850411-07-3 |
98% |
| D956954 |
Glycine,N-(2-chloro-1-oxopropyl)- |
85038-45-5 |
97% |
| Y1260996 |
2-(4-BROMO-PYRAZOL-1-YLMETHYL)-PYRIDINE |
850349-20-1 |
97% |
| Y1265182 |
Necrosis Inhibitor, IM-54 |
861891-50-1 |
99% |
| D491163 |
4-(3-(tert-Butyl)phenyl)tetrahydro-2H-pyran-4-amine |
861857-61-6 |
95% |
| Y1256882 |
4-(Hexadecylamino)benzylamine |
84670-96-2 |
99% |
| Y3211978 |
2-(4-CHLORO-PHENYL)-6-OXO-1,6-DIHYDRO-PYRIMIDINE-4-CARBOXYLIC ACID |
84660-25-3 |
95% |
| Y3213195 |
2(1H)-Isoquinolinepropanoic acid, 3,4-dihydro-, hydrochloride |
846576-15-6 |
95% |
| Y1256857 |
4-[trans-4(trans-4-Propylcyclohexyl) cyclohexyl]toluene 4-[trans-4(trans-4-Propylcyclohexyl)cyclohexyl]toluene |
84656-75-7 |
97% |
| D749379 |
5,6-Dimethylpicolinic acid |
83282-49-9 |
95% |
| Y1290812 |
1-(Bromomethyl)-2-(difluoromethoxy)benzene |
85684-64-6 |
95% |